# Dominari Holdings Inc.: financial statements, quarterly

DOMH · Nasdaq · CIK 12239 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/domh.md) · [Financials](/companies/domh/financials.md) · [Filings](/companies/domh/filings.md) · [Insiders](/companies/domh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/domh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.0](/filings/0001213900-24-095881.md) | [1.0 d](/filings/0001213900-25-031890.md) | [1.4](/filings/0001213900-25-042210.md) | [6.2](/filings/0001213900-25-074425.md) | [4.0](/filings/0001213900-25-107872.md) | [9.4 d](/filings/0001213900-26-036897.md) | [7.2](/filings/0001213900-26-055369.md) | [38.9](/filings/0001437749-26-026832.md) | [50.8](/filings/0001213900-25-107872.md) | [30.1 d](/filings/0001213900-26-036897.md) | [35.8](/filings/0001213900-26-055369.md) | [16.8](/filings/0001437749-26-026832.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [0.0 d](/filings/0001213900-24-095881.md) | [0.0 d](/filings/0001213900-25-031890.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(3.1)](/filings/0001213900-24-095881.md) | [(5.8) d](/filings/0001213900-25-031890.md) | [(2.8)](/filings/0001213900-25-042210.md) | [(2.7)](/filings/0001213900-25-074425.md) | [(3.2)](/filings/0001213900-25-107872.md) | [0.0 d](/filings/0001213900-26-036897.md) | [(32.9)](/filings/0001213900-26-055369.md) | [(14.9)](/filings/0001437749-26-026832.md) | [(1.6)](/filings/0001213900-25-107872.md) | [(2.7) d](/filings/0001213900-26-036897.md) | [(37.6)](/filings/0001213900-26-055369.md) | [(1.1)](/filings/0001437749-26-026832.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-026832.md) | not reported | not reported | [12.9](/filings/0001213900-26-055369.md) | [2.4](/filings/0001437749-26-026832.md) |
| Net income | $m | [(3.5)](/filings/0001213900-24-095881.md) | [(6.9) d](/filings/0001213900-25-031890.md) | [(5.4)](/filings/0001213900-25-042210.md) | [(6.1)](/filings/0001213900-25-074425.md) | [(4.2)](/filings/0001213900-25-107872.md) | [1.1 d](/filings/0001213900-26-036897.md) | [(32.5)](/filings/0001213900-26-055369.md) | [16.6](/filings/0001437749-26-026832.md) | [125](/filings/0001213900-25-107872.md) | [(132) d](/filings/0001213900-26-036897.md) | [(57.4)](/filings/0001213900-26-055369.md) | [(5.0)](/filings/0001437749-26-026832.md) |
| Diluted EPS | $ per share | [(0.66)](/filings/0001213900-24-095881.md) | not reported | [(0.91)](/filings/0001213900-25-042210.md) | [(1.01)](/filings/0001213900-25-074425.md) | [(0.67)](/filings/0001213900-24-095881.md) | not reported | [(3.02)](/filings/0001213900-26-055369.md) | [1.12](/filings/0001213900-25-074425.md) | [7.27](/filings/0001213900-25-107872.md) | not reported | [(3.17)](/filings/0001213900-26-055369.md) | not reported |
| Basic EPS | $ per share | [(0.66)](/filings/0001213900-24-095881.md) | not reported | [(0.91)](/filings/0001213900-25-042210.md) | [(1.01)](/filings/0001213900-25-074425.md) | [(0.67)](/filings/0001213900-25-107872.md) | not reported | [(3.02)](/filings/0001213900-26-055369.md) | [1.12](/filings/0001437749-26-026832.md) | [8.11](/filings/0001213900-25-107872.md) | not reported | [(3.17)](/filings/0001213900-26-055369.md) | [(0.24)](/filings/0001437749-26-026832.md) |

- Revenue: us-gaap:Revenues
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.4](/filings/0001213900-23-083907.md) | [2.8](/filings/0001213900-25-031890.md) | [2.0](/filings/0001213900-24-041336.md) | [5.8](/filings/0001213900-24-066676.md) | [3.4](/filings/0001213900-24-095881.md) | [4.1](/filings/0001213900-26-036897.md) | [6.3](/filings/0001213900-25-042210.md) | [9.5](/filings/0001213900-25-074425.md) | [5.4](/filings/0001213900-25-107872.md) | [34.0](/filings/0001437749-26-026832.md) | [27.5](/filings/0001213900-26-055369.md) | [25.0](/filings/0001437749-26-026832.md) |
| Current assets | $m | [34.9](/filings/0001213900-23-083907.md) | [28.1](/filings/0001213900-25-031890.md) | [25.4](/filings/0001213900-24-041336.md) | [28.8](/filings/0001213900-24-066676.md) | [24.8](/filings/0001213900-24-095881.md) | [28.2](/filings/0001213900-25-107872.md) | [34.7](/filings/0001213900-25-042210.md) | [60.4](/filings/0001213900-25-074425.md) | [206](/filings/0001213900-25-107872.md) | not reported | not reported | not reported |
| Total assets | $m | [63.2](/filings/0001213900-23-083907.md) | [57.6](/filings/0001213900-25-031890.md) | [52.2](/filings/0001213900-24-041336.md) | [49.1](/filings/0001213900-24-066676.md) | [43.4](/filings/0001213900-24-095881.md) | [47.1](/filings/0001213900-26-036897.md) | [52.3](/filings/0001213900-25-042210.md) | [109](/filings/0001437749-26-026832.md) | [223](/filings/0001213900-25-107872.md) | [113](/filings/0001437749-26-026832.md) | [85.3](/filings/0001213900-26-055369.md) | [57.4](/filings/0001437749-26-026832.md) |
| Current liabilities | $m | [1.7](/filings/0001213900-23-083907.md) | [1.6](/filings/0001213900-25-031890.md) | [1.6](/filings/0001213900-24-041336.md) | [3.9](/filings/0001213900-24-066676.md) | [2.4](/filings/0001213900-24-095881.md) | [3.8](/filings/0001213900-25-107872.md) | [6.0](/filings/0001213900-25-042210.md) | [16.5](/filings/0001213900-25-074425.md) | [7.5](/filings/0001213900-25-107872.md) | not reported | not reported | not reported |
| Total liabilities | $m | [4.9](/filings/0001213900-23-083907.md) | [4.6](/filings/0001213900-25-031890.md) | [4.5](/filings/0001213900-24-041336.md) | [6.7](/filings/0001213900-24-066676.md) | [5.2](/filings/0001213900-24-095881.md) | [7.3](/filings/0001213900-26-036897.md) | [9.9](/filings/0001213900-25-042210.md) | [20.7](/filings/0001213900-25-074425.md) | [13.1](/filings/0001213900-25-107872.md) | [43.5](/filings/0001437749-26-026832.md) | [53.7](/filings/0001213900-26-055369.md) | [35.5](/filings/0001437749-26-026832.md) |
| Shareholders' equity | $m | [58.3](/filings/0001213900-24-095881.md) | [52.9](/filings/0001213900-25-042210.md) | [47.7](/filings/0001213900-25-042210.md) | [42.4](/filings/0001213900-24-095881.md) | [38.3](/filings/0001213900-24-095881.md) | [39.9](/filings/0001213900-25-107872.md) | [42.4](/filings/0001213900-25-042210.md) | [88.6](/filings/0001437749-26-026832.md) | [210](/filings/0001213900-25-107872.md) | [69.4](/filings/0001437749-26-026832.md) | [31.6](/filings/0001213900-26-055369.md) | [21.8](/filings/0001437749-26-026832.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.6) d](/filings/0001213900-24-095881.md) | [(4.7) d](/filings/0001213900-25-031890.md) | [(8.6)](/filings/0001213900-25-042210.md) | [1.4 d](/filings/0001213900-25-074425.md) | [(4.7) d](/filings/0001213900-25-107872.md) | [(4.8) d](/filings/0001213900-26-036897.md) | [1.2](/filings/0001213900-26-055369.md) | [(0.4) d](/filings/0001437749-26-026832.md) | [(4.9) d](/filings/0001213900-25-107872.md) | [26.8 d](/filings/0001213900-26-036897.md) | [(28.9)](/filings/0001213900-26-055369.md) | [(9.9) d](/filings/0001437749-26-026832.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001213900-24-095881.md) | [0.0 d](/filings/0001213900-25-031890.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | [7.1](/filings/0001213900-26-055369.md) | [7.0](/filings/0001437749-26-026832.md) | [4.9](/filings/0001437749-26-026832.md) | [(0.1) d](/filings/0001213900-26-036897.md) | [10.0](/filings/0001213900-26-055369.md) | [8.9](/filings/0001437749-26-026832.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.3](/filings/0001213900-23-065013.md) | [5.3](/filings/0001213900-23-083907.md) | [5.3](/filings/0001213900-24-041336.md) | [4.8](/filings/0001213900-24-066676.md) | [5.3](/filings/0001213900-24-095881.md) | [6.0](/filings/0001213900-25-042210.md) | [6.1](/filings/0001213900-25-074425.md) | [6.3](/filings/0001213900-24-095881.md) | [10.8](/filings/0001213900-26-055369.md) | [14.8](/filings/0001213900-25-074425.md) | [17.2](/filings/0001213900-25-107872.md) | [18.1](/filings/0001213900-26-055369.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,243,646 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001437749-26-026832.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.